title: Multiple myeloma developing after imatinib mesylate therapy for chronic myeloid leukemia.
authors: A
authors: A
authors: Galanopoulos
authors: S I
authors: SI
authors: Papadhimitriou
authors: E
authors: E
authors: Kritikou-Griva
authors: M
authors: M
authors: Georgiakaki
authors: N I
authors: NI
authors: Anagnostopoulos
mesh_terms: D000368:Aged; D000970:Antineoplastic Agents / Q000009:adverse effects*; D001549:Benzamides; D006801:Humans; D000068877:Imatinib Mesylate; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy*; D008297:Male; D009101:Multiple Myeloma / Q000139:chemically induced* / Q000175:diagnosis / Q000209:etiology; D010879:Piperazines / Q000009:adverse effects*; D011743:Pyrimidines / Q000009:adverse effects*
chemical_list: D000970:Antineoplastic Agents; D001549:Benzamides; D010879:Piperazines; D011743:Pyrimidines; D000068877:Imatinib Mesylate